Long-Standing Distribution Agreement Between Instrumentation Laboratory and Beckman Coulter Comes to an End
By LabMedica International staff writers Posted on 07 Jun 2012 |
After over 20 years of successful collaboration, Instrumentation Laboratory (Bedford, MA, USA) announced that their Strategic Alliance Cross-Distribution agreement with Beckman Coulter, Inc. (Brea, CA, USA) over their Hemostasis product line will terminate June 22, 2012.
Instrumentation Laboratory, a worldwide developer, manufacturer, and distributor of in vitro diagnostic instruments, related reagents, and controls, will end their distribution partnership with Beckman Coulter, a provider of instrument systems and products for life science. Beginning June 23, 2012, Instrumentation Laboratory will initiate direct sale and support services in the USA and Canada for their own Hemostasis product line in order to improve the quality of their products and services and simplify lab operations.
A strong focus on quality is precisely what has led to Instrumentation Laboratory’s success among hospitals and independent clinical laboratories worldwide, explained Ramon Benet, CEO, Instrumentation Laboratory, who is optimistic about the transition.
“[Instrumentation Laboratory] has achieved significant growth in Hemostasis, culminating in the attainment of the number one market share position worldwide, thanks to our focus on quality and innovation,” said Mr. Benet. “Now is the ideal time for us to apply our expertise, resources, and world-class service organization to working directly with our Hemostasis customers in North America, and focus on ensuring a smooth transition for our customers.”
Instrumentation Laboratories is currently the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer in 1985, the ACL 810, the company has continuously introduced innovative hospital and specialty lab products, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems.
Along with Hemostasis systems, Instrumentation Laboratory’s product lines also include Critical Care and information management systems.
Related Links:
Instrumentation Laboratory
Beckman Coulter
Instrumentation Laboratory, a worldwide developer, manufacturer, and distributor of in vitro diagnostic instruments, related reagents, and controls, will end their distribution partnership with Beckman Coulter, a provider of instrument systems and products for life science. Beginning June 23, 2012, Instrumentation Laboratory will initiate direct sale and support services in the USA and Canada for their own Hemostasis product line in order to improve the quality of their products and services and simplify lab operations.
A strong focus on quality is precisely what has led to Instrumentation Laboratory’s success among hospitals and independent clinical laboratories worldwide, explained Ramon Benet, CEO, Instrumentation Laboratory, who is optimistic about the transition.
“[Instrumentation Laboratory] has achieved significant growth in Hemostasis, culminating in the attainment of the number one market share position worldwide, thanks to our focus on quality and innovation,” said Mr. Benet. “Now is the ideal time for us to apply our expertise, resources, and world-class service organization to working directly with our Hemostasis customers in North America, and focus on ensuring a smooth transition for our customers.”
Instrumentation Laboratories is currently the number one manufacturer of instruments and reagents for the Hemostasis market worldwide. Since the introduction of the first fully automated Hemostasis analyzer in 1985, the ACL 810, the company has continuously introduced innovative hospital and specialty lab products, culminating in the release of the ACL TOP Family of Hemostasis Testing Systems.
Along with Hemostasis systems, Instrumentation Laboratory’s product lines also include Critical Care and information management systems.
Related Links:
Instrumentation Laboratory
Beckman Coulter
Latest Industry News
- ECCMID Congress Name Changes to ESCMID Global
- Bosch and Randox Partner to Make Strategic Investment in Vivalytic Analysis Platform
- Siemens to Close Fast Track Diagnostics Business
- Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics
- Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems
- Sysmex and CellaVision Expand Collaboration to Advance Hematology Solutions
- BD and Techcyte Collaborate on AI-Based Digital Cervical Cytology System for Pap Testing
- Medlab Middle East 2024 to Address Transformative Potential of Artificial Intelligence
- Seegene and Microsoft Collaborate to Realize a World Free from All Diseases and Future Pandemics
- Medlab Middle East 2024 to Highlight Importance of Sustainability in Laboratories
- Fujirebio and Agappe Collaborate on CLIA-Based Immunoassay
- Medlab Middle East 2024 to Highlight Groundbreaking NextGen Medicine
- bioMérieux Acquires Software Company LUMED to Support Fight against Antimicrobial Resistance
- Roche Acquires LumiraDx's Point of Care Technology for USD 295 Million
- Bruker Acquires IVD Manufacturer ELITech Group and Cell Imaging Company Phasefocus
- AMP Publishes Best Practice Guidance for Slice Testing Approach in Diagnostics